Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors
Head & Neck · 2024
DOI: 10.1002/hed.27736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Shivee Gilja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Neck Dissection, Laryngeal Neoplasms, Neoplasm Staging. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I‐II supraglottic laryngeal squamous cell carcinoma (LSCC).
Methods
Trends and factors associated with the use of neck dissection during larynx‐preserving surgery for patients with cT1‐2, N0, M0 supraglottic LSCC in the National Cancer Database (2004–2020) were evaluated using multivariable‐adjusted logistic regression.
Results
Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection.
Conclusions
The results of this national analysis suggest that the utilization of guideline‐concordant neck dissection for management of stage I‐II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Shivee Gilja, Vikram Vasan
Zitieren
APA
Gilja, S., Vasan, V., Kumar, A., Roof, S. A., Genden, E. M., & Kirke, D. N. (2024). Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors. Head & Neck. https://doi.org/10.1002/hed.27736
Vancouver
Gilja S, Vasan V, Kumar A, Roof SA, Genden EM, Kirke DN. Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors. Head & Neck. 2024. doi:10.1002/hed.27736
BibTeX
@article{Gilja2024,
author = {Gilja, Shivee and Vasan, Vikram and Kumar, Arvind and Roof, Scott A and Genden, Eric M and Kirke, Diana N},
title = {Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27736}
}
EUVIMED